WCG Buys E-clinical Software and Translation Provider VeraSci
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
SlatorCon Zurich is now SOLD OUT — See you on October 4th!
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
One of the most attractive pure-play, life sciences players changes hands as RWS bolsters position in fast-growing vertical. Price tag in line with 2015 acquisition of CTi.
Slator Weekly: Join over 15,800 subscribers and get the latest language industry intelligence every Friday
Tool Box: Join 10,000 subscribers for your monthly linguist technology update.
Your information will not be shared with third parties. No Spam.
This will close in 0 seconds